This site is intended for healthcare professionals only

DiabetesontheNet Logo
×


Diabetes Digest

Issue:

Share this article
Share on facebook
Share on twitter
Share on email
Share on print

Type ? diabetes

Diabesity Digest summarises recent key papers published in the area of coexistent diabetes and obesity – diabesity. To compile the digest a PubMed search was performed for the 3 months ending August 2015 using a range of search terms relating to type 2 diabetes, obesity and diabesity. Articles have been chosen on the basis of their potential interest to healthcare professionals involved in the care of people with diabesity. The articles were rated according to readability, applicability to practice, and originality.

Diabetes used to be so simple. There was only type 1 and type 2 – now there’s  surgically induced; gestational and drug-induced iatrogenic diabetes; and maturity-onset diabetes of the young (MODY); latent autoimmune diabetes (LADA); and schizophrenia-associated diabetes – things have become complicated. Dementia experts have described Alzheimer’s disease as type 3 diabetes (de la Monte and Wands, 2008) without realising that we’re almost in double figures already without their help. This column has discussed “double diabetes” (Haslam, 2103) following on from a DCCT (Diabetes Control and Complications Trial) follow-up study (Purnell et al, 2013), which demonstrated that people with type 1 diabetes are having metabolic syndrome thrust upon them because of insulin-related weight gain, the subsequent insulin resistance rendering insulin control for diabetes management more troublesome.

Obesity has been linked with type 1 diabetes before (Verbeeten et al, 2011), prompting further calls for improved obesity prevention measures. Many commentators are convinced that type 1 and type 2 diabetes are merely different manifestations of the same condition, separated by speed of onset alone. Terry Wilkin (2012) recently declared, as part of his “accelerator hypothesis”, that “It seems likely that type 1 and type 2 diabetes lie at different points of the same spectrum, separated by the misunderstanding that one belongs to childhood and the other to adulthood. The spectrum is that of tempo – the rate at which beta-cell function is lost over time. A combination of beta-cell up-regulation (insulin demand, largely determined by obesity) and the genetically determined immune response to it (‘autoimmunity’) determines tempo, ranging from slow to fast with every variant in between”. Now the boundaries are becoming more and more blurred.

Two articles published over recent months have further stirred the muck. In a study of over 1.25 million people, the paper by Hussen et al (summarised on the next page) reached a completely counter-intuitive conclusion: in their own words – “The risk of type 1 diabetes was increased in offspring of parents with any type of diabetes regardless of parental ethnicity. High first trimester maternal BMI was associated with increased risk of type 1 diabetes only in offspring of parents without diabetes”. So type 2 diabetes in parents and high BMI in mothers increase the risk of type 1 diabetes in kids! This phenomenon requires a lot more research before we can entirely embrace the concept of type 1 and type 2 being so closely linked, but evidence such as this is certainly thought provoking.

The second paper, a French study by Robert et al, summarised on the next page, is a very small study, which observed the effect of intentional weight loss by bariatric surgery in people with type 1 diabetes compared to those with type 2 diabetes. It demonstrates an improvement rate of 90% (but no remission), improvement of insulin resistance, reduction in the number of units of insulin required, and a high rate of remission of hypertension and dyslipidaemia in the type 1 diabetes group. Therefore, there is a considerable reduction in the burden of the components of metabolic syndrome – partly caused by the anabolic effects of insulin – and a reduction in the amount of insulin, which caused the problem in the first place.

So whether or not we believe Terry Wilkin’s theory that the same illness affects us in different ways, it is notable at least that type 1 diabetes and type 2 diabetes are mentioned in the same breath with regard to aetiology and treatment.

To view the summaries of each paper, please download the PDF of this article

de la Monte SM, Wands JR (2008) Alzheimer’s disease is type 3 diabetes – evidence reviewed. J Diabetes Sci Technol 2: 1101–13
Haslam D (2013) DCCT/EDIC update: What are the real causes of diabetes complications? Diabesity in Practice 2: 78–9
Purnell JQ, Zinman B, Brunzell JD et al (2013) The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study. Circulation 127: 180–7
 Verbeeten KC, Elks CE, Daneman D, Ong KK (2011) Association between childhood obesity and subsequent Type 1 diabetes: a systematic review and meta-analysis. Diabet Med 28: 10–8
 Wilkin TJ (2012) The convergence of type 1 and type 2 diabetes in childhood: the accelerator hypothesis. Pediatr Diabetes 13: 334–9

Share this article
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on whatsapp
Related content
For the latest news and articles

Sign up to all DiabetesontheNet journals

© Copyright Omniamed Communications. All Rights Reserved​
108 Cannon Street, London, EC4N 6EU. Registered in the United Kingdom​
Omniamed logo white
DiabetesontheNet Logo
For the latest news and articles

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

DiabetesontheNet Logo

This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.